欧州連合 - アイスランド語 - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - Öll önnur lækningavörur - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

gilead sciences ireland uc - cobicistat - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 100 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 200 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 25 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 50 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

janssen-cilag ab - topiramatum inn - hart hylki - 15 mg

欧州連合 - アイスランド語 - EMA (European Medicines Agency)

neovii biotech gmbh - catumaxomab - ascites; cancer - Önnur æxlishemjandi lyf - removab er ætlað til að meðhöndla illkynja öndunarfærasjúkdóma hjá sjúklingum með epcam jákvæða krabbamein þar sem hefðbundin meðferð er ekki tiltæk eða ekki lengur unnt.

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg

アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml